← Leaderboards
Steven M Greenberg
Massachusetts General Hospital
$39,743,346
Attributed
$42,586,803
Total exposure
15
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $16.4M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$110,863,486 · 17
By mechanism
U19$62,646,087 · 1
R01$19,955,886 · 7
U24$18,859,859 · 2
P50$5,630,596 · 1
U10$2,261,964 · 1
K24$926,792 · 1
Top collaborators
- Brian J Bacskai6 shared
- Natalia S Rost6 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Anand Viswanathan$12,542,460
- Mahmut Edip Gurol$5,412,188
- Jonathan Rosand$24,467,190
- Karen L. Furie$5,939,373
- Brian J Bacskai$26,389,294
Others in their field
Top investigators on “Blood Vessels”
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Charles Decarli · University Of California At Davis$66,498,201
- Josef Coresh · New York University School Of Medicine$63,693,760
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$62,000,770
- Robert P Kimberly · University Of Alabama At Birmingham$56,093,149
Research focus
Blood VesselsBrainBaseFutureAlzheimer&AposStrokeClinical ResearchMagnetic Resonance ImagingClinical TrialsSuccessPrincipal InvestigatorLeadershipImpaired CognitionPreventPathologyCerebral Hemisphere HemorrhageCerebral Amyloid AngiopathyResearch PersonnelFundingLifeDesignS DiseaseMassachusettsSkills
Grant awards (77)
VCID Biomarkers Coordinating Center$2,286,910
U24 · FY2025 · NS · contact PI
Mechanisms of Vasomotion-mediated Perivascular Clearance in Cerebral Amyloid Angiopathy$536,695
R01 · FY2025 · NS · contact PI
DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY$16,362,355
U19 · FY2024 · NS
DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY$13,954,895
U19 · FY2023 · NS
VCID Biomarkers Coordinating Center$1,251,249
U24 · FY2023 · NS · contact PI
VCID Biomarkers Coordinating Center$6,955,795
U24 · FY2022 · NS · contact PI
DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY$2,150,794
U19 · FY2022 · NS
DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY$14,058,964
U19 · FY2021 · NS
Harvard Partners Neurology NEXT Clinical Trial Site$339,240
U24 · FY2021 · NS · contact PI
DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY$11,092,441
U19 · FY2020 · NS
VCID Biomarker's Coordinating Center$1,282,500
U24 · FY2020 · NS · contact PI
CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION$1,134,301
R01 · FY2020 · NS · contact PI
Harvard Partners Neurology NEXT Clinical Trial Site$339,240
U24 · FY2020 · NS · contact PI
DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY$5,026,638
U19 · FY2019 · NS
VCID Biomarker's Coordinating Center$1,282,500
U24 · FY2019 · NS · contact PI
CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION$1,133,666
R01 · FY2019 · NS · contact PI
Vascular Dysfunction in Cerebral Amyloid Angiopathy$698,333
R01 · FY2019 · AG · contact PI
Harvard Partners Neurology NEXT Clinical Trial Site$339,240
U24 · FY2019 · NS · contact PI
VCID Biomarker's Coordinating Center$1,282,500
U24 · FY2018 · NS · contact PI
CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION$1,133,666
R01 · FY2018 · NS · contact PI
Vascular Dysfunction in Cerebral Amyloid Angiopathy$713,214
R01 · FY2018 · AG · contact PI
VCID Biomarker's Coordinating Center$472,269
U24 · FY2018 · NS · contact PI
Harvard Partners Neurology NEXT Clinical Trial Site$356,365
U24 · FY2018 · NS · contact PI
VCID Biomarker's Coordinating Center$112,731
U24 · FY2018 · NS · contact PI
VCID Biomarker's Coordinating Center$1,276,820
U24 · FY2017 · NS · contact PI
CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION$1,133,666
R01 · FY2017 · NS · contact PI
Vascular Dysfunction in Cerebral Amyloid Angiopathy$710,360
R01 · FY2017 · AG · contact PI
Harvard Partners Neurology NEXT Clinical Trial Site$348,596
U10 · FY2017 · NS · contact PI
VCID Biomarker's Coordinating Center$1,282,500
U24 · FY2016 · NS · contact PI
CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION$1,037,212
R01 · FY2016 · NS · contact PI
Vascular Dysfunction in Cerebral Amyloid Angiopathy$713,322
R01 · FY2016 · AG · contact PI
Harvard Partners Neurology NEXT Clinical Trial Site$348,596
U10 · FY2016 · NS · contact PI
CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION$114,404
R01 · FY2016 · NS · contact PI
International Cerebral Amyloid Angiopathy Conference in Boston$10,000
R13 · FY2016 · NS · contact PI
Vascular Dysfunction in Cerebral Amyloid Angiopathy$703,727
R01 · FY2015 · AG · contact PI
Harvard Partners Neurology NEXT Clinical Trial Site$280,096
U10 · FY2015 · NS · contact PI
Vascular Dysfunction in Cerebral Amyloid Angiopathy$560,890
R01 · FY2014 · AG · contact PI
Early Detection of Cerebral Amyloid Angiopathy$460,174
R01 · FY2014 · NS · contact PI
Harvard Partners Neurology NEXT Clinical Trial Site$326,707
U10 · FY2014 · NS · contact PI
Specialized Programs of Translational Research in Acute Stroke at the Partners$2,788,471
P50 · FY2013 · NS · contact PI
Vascular Dysfunction in Cerebral Amyloid Angiopathy$532,513
R01 · FY2013 · AG · contact PI
Early Detection of Cerebral Amyloid Angiopathy$447,684
R01 · FY2013 · NS · contact PI
Harvard Partners Neurology NEXT Clinical Trial Site$242,152
U10 · FY2013 · NS · contact PI
Specialized Programs of Translational Research in Acute Stroke at the Partners$2,842,125
P50 · FY2012 · NS · contact PI
Vascular Dysfunction in Cerebral Amyloid Angiopathy$564,849
R01 · FY2012 · AG · contact PI
Early Detection of Cerebral Amyloid Angiopathy$463,025
R01 · FY2012 · NS · contact PI
Harvard Partners Neurology NEXT Clinical Trial Site$345,781
U10 · FY2012 · NS · contact PI
Vascular Dysfunction in Cerebral Amyloid Angiopathy$566,186
R01 · FY2011 · AG · contact PI
Early Detection of Cerebral Amyloid Angiopathy$463,559
R01 · FY2011 · NS · contact PI
Harvard Partners Neurology NEXT Clinical Trial Site$370,036
U10 · FY2011 · NS · contact PI
Vascular Dysfunction in Cerebral Amyloid Angiopathy$557,292
R01 · FY2010 · AG · contact PI
Early Detection of Cerebral Amyloid Angiopathy$507,128
R01 · FY2010 · NS · contact PI
Clinical, Radiographic, and Genetic Associations in Cerebral Amyloid Angiopathy$193,236
K24 · FY2010 · NS · contact PI
Vascular Dysfunction in Cerebral Amyloid Angiopathy$234,074
R01 · FY2009 · AG · contact PI
Clinical, Radiographic, and Genetic Associations in Cerebral Amyloid Angiopathy$189,180
K24 · FY2009 · NS · contact PI
Vascular Dysfunction in Cerebral Amyloid Angiopathy$234,273
R01 · FY2008 · AG · contact PI
Clinical, Radiographic, and Genetic Associations in Cerebral Amyloid Angiopathy$185,244
K24 · FY2008 · NS · contact PI
Genetic Risks for Medication-Related Hemorrhagic Stroke$389,584
R01 · FY2007 · NS · contact PI
Vascular Dysfunction in Cerebral Amyloid Angiopathy$239,054
R01 · FY2007 · AG · contact PI
Clinical, Radiographic, and Genetic Associations in Cerebral Amyloid Angiopathy$181,422
K24 · FY2007 · NS · contact PI
Genetic Risks for Medication-Related Hemorrhagic Stroke$401,220
R01 · FY2006 · NS · contact PI
Vascular Dysfunction in Cerebral Amyloid Angiopathy$246,401
R01 · FY2006 · AG · contact PI
Clinical, Radiographic, and Genetic Associations in Cerebral Amyloid Angiopathy$177,710
K24 · FY2006 · NS · contact PI
Genetic Risks for Medication-Related Hemorrhagic Stroke$410,875
R01 · FY2005 · NS
NC-758 for Prevention of Recurrent Cerebral Hemorrhage$381,840
R01 · FY2005 · NS
Vascular Dysfunction in Cerebral Amyloid Angiopathy$257,874
R01 · FY2005 · AG
PTS WITH LOBAR CEREBRAL HEMORRHAGE RELATED TO CEREBRAL AMYLOID ANGIOPATHY$2,391
M01 · FY2005 · RR
Genetic Risks for Medication-Related Hemorrhagic Stroke$410,875
R01 · FY2004 · NS
NC-758 for Prevention of Recurrent Cerebral Hemorrhage$381,840
R01 · FY2004 · NS
PTS WITH LOBAR CEREBRAL HEMORRHAGE RELATED TO CEREBRAL AMYLOID ANGIOPATHY$50,329
M01 · FY2004 · RR
Genetic Risks for Medication-Related Hemorrhagic Stroke$410,875
R01 · FY2003 · NS
NC-758 for Prevention of Recurrent Cerebral Hemorrhage$379,235
R01 · FY2003 · NS
Spatial and temporal progression of amyloid angiopathy$346,000
R01 · FY2003 · AG
Spatial and temporal progression of amyloid angiopathy$346,000
R01 · FY2002 · AG
EFFECT OF DONEPEZIL IN ALZHEIMER'S DISEASE$415,629
M01 · FY2000 · RR
MOLECULAR RISK FACTORS FOR CEREBRAL AMYLOID ANGIOPATHY$103,378
K08 · FY2000 · AG
EFFECT OF DONEPEZIL IN ALZHEIMER'S DISEASE$575
M01 · FY2000 · RR